Chembio Diagnostics (CEMI) has a STRONG forecast
What’s up with Chembio Diagnostics?
Chembio Diagnostics (CEMI) opened at $12.54, which means the stock is up 7.00% from yesterday’s closing price of 12.70. Today, the company has a high of $12.82 and a low of $11.46. The company has a market cap of $214.97 million with a 52-week high of $15.89 and a 52-week low of $2.25.
What about the future for Chembio Diagnostics?
The high forecast for Chembio Diagnostics is 23.00 while the low is 15.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Chembio Diagnostics has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information CEMI seems to be a safe buy.
About Chembio Diagnostics
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.